Guardant Health, Inc. Logo

Guardant Health, Inc. (1GH)

MTA

Currency in EUR
140.22
-6.12 (-4.18%)

Closed

Aug 24, 2026

Day's Range

140.22
147.36

52 wk Range

42.00
153.70

Overview - 1GH - Guardant Health, Inc.

Key Statistics

Valuation

Enterprise Value

16.66B

P/E (Trailing)

‪-42.23‬

PEG Ratio

‪-3.37‬

Price / Sales (TTM)

‪15.90‬

Price / Book

‪-83.59‬

EV / EBITDA

‪-45.19‬

Profitability

Gross Margin

‪65.38%‬

Profit Margin

‪-38.32%‬

Operating Margin

‪-38.24%‬

Return on Assets

‪-18.07%‬

Return on Equity

‪419.18%‬

Ownership

Shares Outstanding

133.61M

Float

129.39M

Held by Insiders

‪3.97%‬

Held by Institutions

‪100.91%‬

Price stats

Beta

‪1.58‬

50-Day Avg

‪135.33‬

200-Day Avg

‪99.60‬

Dividends

Payout Ratio

‪0.00%‬

Market Cap - 1GH - Guardant Health, Inc.

Peers - 1GH - Guardant Health, Inc.

Peer Comparison

Compared with companies in Diagnostics & Research listed on MTA.

Profile Summary - 1GH - Guardant Health, Inc.

About

Guardant Health Inc. is a precision oncology company that develops and provides blood and tissue-based tests, along with vast data sets and advanced analytics, to support cancer treatment, monitoring, and early detection. Its core offerings include the Guardant360 family of liquid biopsy tests, such as Guardant360 CDx…

SectorHealthcare
IndustryDiagnostics & Research
Employees2.49K
Full company profile

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Stocks news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.